Literature DB >> 6608488

Non-specific factor enhancement of human in vitro antigen-dependent antibody synthesis: role of B cell activation and T cell help.

M K Brenner, M E North, H R Chadda, J Farrant.   

Abstract

Lectin-free supernatants obtained from PWM-stimulated lymphocytes, enable B cells to proliferate and secrete immunoglobulin. Both functions are augmented by the addition of irradiated T cells. In the presence of antigen, these supernatants also enhance specific anti-tetanus toxoid antibody production. The components of the supernatant responsible for these activities have a molecular weight between 30,000 and 60,000, and have the characteristics of non-specific factors: they are genetically unrestricted, and do not bind to either antigen or anti-DR affinity columns. There is no evidence that the partial T dependency of these factors is an indication that their target is a T cell. Instead, T cells appear necessary to move the B cell into a state of activation in which it becomes responsive to the factor. Alternative activation signals such as Staph. A. Cowan can substitute for T cell help in the proliferative response, but not for immunoglobulin or antibody synthesis. The implications of these results for the approaches used to detect and classify B cell growth factors are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608488      PMCID: PMC1454564     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

Review 1.  A third signal in B cell activation given by TRF.

Authors:  A Schimpl; E Wecker
Journal:  Transplant Rev       Date:  1975

2.  Letter: T cell-dependent mediator in the immune response.

Authors:  H Waldmann; A Munro
Journal:  Nature       Date:  1973-06-08       Impact factor: 49.962

3.  Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures.

Authors:  O Sjöberg; J Andersson; G Möller
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

4.  T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level.

Authors:  J Andersson; M H Schreier; F Melchers
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

5.  Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture.

Authors:  J Farrant; J C Clark; H Lee; S C Knight; J O'Brien
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Antigen-specific and nonspecific mediators of T cell/B cell cooperation. I. Evidence for their production by different T cells.

Authors:  P C Marrack; J W Kappler
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

7.  Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen.

Authors:  R K Schuurman; E W Gelfand; H M Dosch
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

8.  In vitro studies on H-2-linked unresponsiveness to synthetic polypeptides. III. Production of an antigen-specific T helper cell factor to (T,G)-A--L.

Authors:  S Howie; M Feldman
Journal:  Eur J Immunol       Date:  1977-07       Impact factor: 5.532

9.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  Antigen-specific helper factor in man.

Authors:  F B Mudawwar; E J Yunis; R S Geha
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  1 in total

1.  Biochemical and physiochemical characteristics of a pre-B cell stimulating factor produced by the plasmacytoma cell line LICR LON HMY2.

Authors:  A Trudgett; A C Fay; J M Thompson; T A McNeill
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.